Filter posts

Another Year, Another Misleading Insurance Company Report

Once again, Blue Cross Blue Shield is out with a report attempting to stoke fear …

Survey Says: Solutions to Combat Against Antimicrobial Resistance Needed

Writing for The Hill, Dr. Cynthia Sears, president of the Infectious Diseases Society of America …

Patient and Health Advocacy Summit: Ensuring Patient Access and Affordability

In a world of continual innovation in biopharmaceuticals, how do we ensure patients have access …

BIO Patient & Health Advocacy Summit Concludes Today

Each year BIO brings the patient stakeholder community together for the BIO Patient and Health …

Patient Advocates Sounding the Alarm Over Fail First

The Centers for Medicare & Medicaid Services (CMS) has reversed a long-standing policy allowing Medicare …

Making SMA Newborn Screening a Reality: Collaborating with the Patient Advocacy Community

Each year, roughly 12,500 newborns in the U.S., or one out of every 300 infants, …

Watchdog Report Reaffirms Concerns With Fail First

A new report by the Office of Inspector General at the U.S. Department of Health …

2018 BIO Investor Forum Wraps Up

As the stock market continued its volatile swings this week, investors at the BIO Investor …

BIO Investor Forum Explores “Digiceuticals” as a New Class of FDA-Approved Therapeutics

Within the past year, the FDA has launched a provider pre-certification program as a pilot …

A Patient-Centric Approach to Investing & Partnering

Thursday’s Plenary Luncheon Fireside Chat at the 2018 BIO Investor Forum (BIF) featured two industry leaders: …